← Back to Search

Experimental for Critical Illness (UC-COVID Trial)

N/A
Waitlist Available
Led By Lauren E Wisk, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month, 6 months
Awards & highlights

UC-COVID Trial Summary

The novel coronavirus (COVID-19) is affecting the way many people live their lives, including seeking medical care and maintaining good self-care to keep healthy. Additionally, in the event many people become critically ill at once, COVID-19 has the possibility of overwhelming hospitals to the point where they have to make decisions about how to determine who receives intensive care and life-support measures. Many hospitals as well as local or state governments have been working on policies to determine how to make these decisions. This study seeks to learn about how COVID-19 has affected the way patients and healthcare providers care for themselves and about their thoughts and concerns about policies that may "ration" life-support resources.

Eligible Conditions
  • Critical Illness
  • Coronavirus
  • Health Behaviors
  • Attitude of Health Personnel
  • Health Literacy
  • Health Care Utilization

UC-COVID Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in anxiety surrounding SRA policy
Improvement in knowledge surrounding SRA policy
Improvement in trust surrounding SRA policy

UC-COVID Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Subjects will be provided a brief educational intervention prior to completing follow up survey about SRA attitudes and knowledge
Group II: ControlActive Control1 Intervention
Subjects will not be provided any prior to completing follow up survey about SRA attitudes and knowledge

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,533 Previous Clinical Trials
10,263,068 Total Patients Enrolled
2 Trials studying Critical Illness
209 Patients Enrolled for Critical Illness
Lauren E Wisk, PhDPrincipal InvestigatorDivision of General Internal Medicine & Health Services Research, UCLA
Russell G Buhr, MD, PhDPrincipal InvestigatorDivision of Pulmonary & Critical Care Medicine, UCLA

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
The LancetJournal
Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study
Zhou, Fei, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, et al.. 2020. “Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study”. The Lancet. Elsevier BV. doi:10.1016/s0140-6736(20)30566-3.
International Journal of Infectious DiseasesJournal
Prevalence of Comorbidities and Its Effects in Patients Infected with Sars-cov-2: A Systematic Review and Meta-analysis
Yang, Jing, Ya Zheng, Xi Gou, Ke Pu, Zhaofeng Chen, Qinghong Guo, Rui Ji, Haojia Wang, Yuping Wang, and Yongning Zhou. 2020. “Prevalence of Comorbidities and Its Effects in Patients Infected with Sars-cov-2: A Systematic Review and Meta-analysis”. International Journal of Infectious Diseases. Elsevier BV. doi:10.1016/j.ijid.2020.03.017.
clinicaltrials.govStudy
Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19
Russell G. Buhr, MD, PhD 2020. "Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04373135.
All > Covid
~500 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top